153 related articles for article (PubMed ID: 9456116)
1. MRI as an alternative to CT-guided biopsy of adrenal masses in patients with lung cancer.
Schwartz LH; Ginsberg MS; Burt ME; Brown KT; Getrajdman GI; Panicek DM
Ann Thorac Surg; 1998 Jan; 65(1):193-7. PubMed ID: 9456116
[TBL] [Abstract][Full Text] [Related]
2. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
Porte HL; Ernst OJ; Delebecq T; Métois D; Lemaitre LG; Wurtz AJ
Eur J Cardiothorac Surg; 1999 May; 15(5):597-601. PubMed ID: 10386403
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two algorithms and their associated charges when evaluating adrenal masses in patients with malignancies.
Schwartz LH; Panicek DM; Doyle MV; Ginsberg MS; Herman SK; Koutcher JA; Brown KT; Getrajdman GI; Burt M
AJR Am J Roentgenol; 1997 Jun; 168(6):1575-8. PubMed ID: 9168729
[TBL] [Abstract][Full Text] [Related]
4. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
Burt M; Heelan RT; Coit D; McCormack PM; Bains MS; Martini N; Rusch V; Ginsberg RJ
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):584-8; discussion 588-9. PubMed ID: 8302078
[TBL] [Abstract][Full Text] [Related]
6. Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis.
Remer EM; Obuchowski N; Ellis JD; Rice TW; Adelstein DJ; Baker ME
AJR Am J Roentgenol; 2000 Apr; 174(4):1033-9. PubMed ID: 10749246
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer.
Ettinghausen SE; Burt ME
J Clin Oncol; 1991 Aug; 9(8):1462-6. PubMed ID: 1649268
[TBL] [Abstract][Full Text] [Related]
8. Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies.
Paulsen SD; Nghiem HV; Korobkin M; Caoili EM; Higgins EJ
AJR Am J Roentgenol; 2004 Apr; 182(4):1033-7. PubMed ID: 15039183
[TBL] [Abstract][Full Text] [Related]
9. [Value of puncture-biopsy under computed tomography of adrenal masses associated with bronchial cancer].
Wurtz A; Robert Y; Lemaitre L; Gambiez L; Porte H; Taieb S; Gosselin B
Ann Chir; 1993; 47(8):791-6. PubMed ID: 8311415
[TBL] [Abstract][Full Text] [Related]
10. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
13. Collision tumors of the adrenal gland: demonstration and characterization at MR imaging.
Schwartz LH; Macari M; Huvos AG; Panicek DM
Radiology; 1996 Dec; 201(3):757-60. PubMed ID: 8939227
[TBL] [Abstract][Full Text] [Related]
14. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
Wu YW; Tan CH
Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
[TBL] [Abstract][Full Text] [Related]
15. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases.
McNicholas MM; Lee MJ; Mayo-Smith WW; Hahn PF; Boland GW; Mueller PR
AJR Am J Roentgenol; 1995 Dec; 165(6):1453-9. PubMed ID: 7484585
[TBL] [Abstract][Full Text] [Related]
16. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
[TBL] [Abstract][Full Text] [Related]
17. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
18. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
[TBL] [Abstract][Full Text] [Related]
19. Value of chemical shift subtraction MRI in characterization of adrenal masses.
Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
[TBL] [Abstract][Full Text] [Related]
20. Distinction between adrenal adenomas and metastases using MR imaging.
Reinig JW; Doppman JL; Dwyer AJ; Johnson AR; Knop RH
J Comput Assist Tomogr; 1985; 9(5):898-901. PubMed ID: 4031166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
